Ticlopidine
CAS No. 55142-85-3
Ticlopidine ( —— )
Catalog No. M17538 CAS No. 55142-85-3
Ticlopidine is an antiplatelet drug in the thienopyridine family which is an adenosine diphosphate (ADP) receptor inhibitor.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 58 | In Stock |
|
50MG | 87 | In Stock |
|
100MG | 132 | In Stock |
|
500MG | 332 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTiclopidine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTiclopidine is an antiplatelet drug in the thienopyridine family which is an adenosine diphosphate (ADP) receptor inhibitor.
-
DescriptionTiclopidine is an antiplatelet drug in the thienopyridine family which is an adenosine diphosphate (ADP) receptor inhibitor.
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorADP
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number55142-85-3
-
Formula Weight263.78
-
Molecular FormulaC14H14ClNS
-
Purity98%
-
Solubility——
-
SMILESC1CN(Cc2c1scc2)Cc1ccccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Maffrand, JP (2012). Comptes Rendus Chimie. 15 (8): 737–743.
molnova catalog
related products
-
PD153035 hydrochlori...
PD153035 hydrochloride (ZM 252868; AG 1517) is a potent and specific inhibitor of EGFR with Ki and IC50 of 5.2 pM and 29 pM; little effect against PGDFR, FGFR, CSF-1, InsR and Src.
-
Beta-Hydroxyisovaler...
Beta-Hydroxyisovalerylshikonin is an inhibitor of protein-tyrosine kinases such as v-Src and EGFR, and has been shown to induce apoptosis in several human tumor cell lines. Beta-Hydroxyisovalerylshikonin significantly decreased viability of HCT116 cells (IC50 values = 30.9 μg/mL).
-
E4CPG
E4CPG is a novel group I/II metabotropic glutamate receptor antagonist, more potent than (RS)-MCPG.